David M. Kent

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke

David M. Kent, Robin Ruthazer, Christian Weimar et al. · Neurology · 2013 · 627 citations · Full text

Medicine, Neurology, Neurosurgery +17

Limitations of Applying Summary Results of Clinical Trials to Individual Patients

David M. Kent, Rodney A. Hayward · JAMA · 2007 · 506 citations

Medicine, Neurology, Otolaryngology +6

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

David M. Kent, Peter M. Rothwell, John P. A. Ioannidis et al. · Trials · 2010 · 502 citations · Full text

Public Health, Biostatistics, Causal Inference +16

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

David M. Kent, Jessica K. Paulus, David van Klaveren et al. · Annals of Internal Medicine · 2019 · 432 citations · Full text

Public Health, Biostatistics, Causal Inference +16

Three simple rules to ensure reasonably credible subgroup analyses

James Burke, Jeremy B. Sussman, David M. Kent et al. · BMJ · 2015 · 315 citations · Full text

Public Health, Biostatistics, Bayesian Biostatistics +10